Atomoxetine reverses attentional deficits produced by noradrenergic deafferentation of medial prefrontal cortex
Open accessThe DOI matches its Crossref record; 77 of the 77 references it cites were found in a registry or an index.
Abstract
Background The majority of studies assessing executive function in attention deficit disorder (ADD) have shown deficits in attentional set shifting using either the Wisconsin card sorting task or the intra-dimensional/extra-dimensional set-shifting task (ID/ED). Damage to the prefrontal cortex in humans, primates, and rodents impairs extra-dimensional (ED) shifts. Noradrenergic depletion of the medial prefrontal cortex in rats is sufficient to impair attentional set shifting. Atomoxetine, a selective norepinephrine (NE) re-uptake inhibitor, is hypothesized to produce beneficial effects in patient with ADD by augmenting NE release in prefrontal cortex.Materials and methods We assessed the effects of systemic administration of atomoxetine (0.0, 0.1, 0.3, and 0.9 mg/kg/ml) in normal and noradrenergically lesioned (NE-LX) rats on attentional-set shifts. We replicated findings showing NE-LX rats are selectively impaired on the ED shifts but not reversals or other discriminations.Results Atomoxetine remediated the attentional set-shifting impairments in NE-LX rats but impaired ED performance of non-lesioned rats.Discussion Though atomoxetine is neurochemically selective, it is not wholly specific at doses >0.3 mg/kg. All doses of the drug were similar in their efficacy in reversing the ED deficit, but the effectiveness of the 0.1 mg/kg dose supports the hypothesis that increases in prefrontal NE alone are sufficient to improve attention in NE-LX rats. Moreover, the detrimental effects of the drug in non-lesioned rats support the hypothesis that optimal levels of NE in prefrontal cortex are critical to attentional set shifting with both supra- and sub-optimal levels producing attentional impairments.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The serotonin and norepinephrine reuptake inhibitor atomoxetine was able to rescue the deficits in ED caused by deafferentiation”
From Prefrontal cortex executive processes affected by stress in health and disease (2018) · cites this paper as Newman et al 2008
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Atomoxetine improves measures of PFC cognitive function in rats (Newman et al., 2008; Robinson et al., 2008; Seu et al., 2009), monkeys (Gamo et al., 2010; Seu et al., 2009), and humans (Chamberlain et al., 2007; Chamberlain et al., 2006).”
From Catecholamine influences on prefrontal cortical function: Relevance to treatment of attention deficit/hyperactivity disorder and related disorders (2011) · cites this paper as Newman et al., 2008
In the citing paper
“presumably by preventing reuptake of norepinephrine released from the residual intact adrenergic terminals (Newman et al 2008).”
From Prefrontal cortex executive processes affected by stress in health and disease (2018) · cites this paper as Newman et al 2008
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Rat Brain in Stereotaxic Coordinates
(1982) · Elsevier eBooks · doi:10.1016/c2009-0-63235-9 · Cited by 51,963
Aston-Jones, G., & Cohen, J. D. (2005) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.28.061604.135709 · Cited by 4,472 · cited 2×
“Norepinehrine has been shown to be critical to selective attention (Devauges and Sara 1990; Aston-Jones et al. 1994; Aston-Jones et al. 2000; Dalley et al. 2001; Dalley et al. 2004; Aston-Jones and Cohen 2005) and attentional set shifting (Lapiz and Morilak 2006; Lapiz et al.”
Drug abuse: hedonic homeostatic dysregulation
Koob, G. F., & Moal, M. L. (1997) · Science · doi:10.1126/science.278.5335.52 · Cited by 2,535 · cited 1×
“It is hypothesized that increases in accumbens dopamine levels underlie the addictive properties of stimulants (Koob and LeMoal 1997), so decreasing the addiction liability may require compounds that produce minimal changes in subcortical dopamine.”
Neuroscience of attention-deficit/hyperactivity disorder: the search for endophenotypes
Castellanos, F. X., & Tannock, R. (2002) · Nature Reviews Neuroscience · doi:10.1038/nrn896 · Cited by 1,827 · cited 2×
“…in attention deficit disorder (ADD) while many studies support a role for dopaminergic dysfunction (Barkley 1997; Sagvolden and Sergeant 1998; Castellanos and Tannock 2002; Viggiano et al. 2004b), and recent data suggest that dysfunction in norepinephrine (NE) may also contribute to…”
Dissociation in prefrontal cortex of affective and attentional shifts
Dias, R., Robbins, T. W., & Roberts, A. C. (1996) · Nature · doi:10.1038/380069a0 · Cited by 1,527 · cited 2×
“During the extra-dimensional shift, a previously irrelevant attribute predicts reward requiring subjects to disengage attention from the previously relevant attribute and learn that a new attribute predicts reinforcement (Owen et al. 1991, 1993; Dias et al. 1996a, b; Birrell and Brown 2000).”
Medial Frontal Cortex Mediates Perceptual Attentional Set Shifting in the Rat
Birrell, J. M., & Brown, V. J. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-11-04320.2000 · Cited by 1,421 · cited 1×
“During the extra-dimensional shift, a previously irrelevant attribute predicts reward requiring subjects to disengage attention from the previously relevant attribute and learn that a new attribute predicts reinforcement (Owen et al. 1991, 1993; Dias et al. 1996a, b; Birrell and Brown 2000).”
Prefrontal executive and cognitive functions in rodents: neural and neurochemical substrates
Dalley, J. W., Cardinal, R. N., & Robbins, T. W. (2004) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2004.09.006 · Cited by 1,329 · cited 1×
“…has been shown to be critical to selective attention (Devauges and Sara 1990; Aston-Jones et al. 1994; Aston-Jones et al. 2000; Dalley et al. 2001; Dalley et al. 2004; Aston-Jones and Cohen 2005) and attentional set shifting (Lapiz and Morilak 2006; Lapiz et al. 2007; Tait et al. 2007).”
Bymaster, F. (2002) · Neuropsychopharmacology · doi:10.1016/s0893-133x(02)00346-9 · Cited by 1,123 · cited 8×
“Though atomoxetine is highly selective for the NE transporter, the 0.6 mg/kg dose increases the levels of NE and dopamine in frontal cortex, and this simultaneous release may be necessary to show beneficial effects on response inhibition (Bymaster et al. 2002).”
InfluentialNeurobiology of Executive Functions: Catecholamine Influences on Prefrontal Cortical Functions
Arnsten, A. F. T., & Li, B.-M. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2004.08.019 · Cited by 948
How specific is a deficit of executive functioning for attention-deficit/hyperactivity disorder?
Sergeant, J. A., Geurts, H., & Oosterlaan, J. (2002) · Behavioural Brain Research · doi:10.1016/s0166-4328(01)00430-2 · Cited by 784 · cited 1×
“In contrast to work in adults, Sergeant and colleagues showed that a majority of studies using tests of executive function consistently differentiated the performance of children with ADD from control subjects (Sergeant et al. 2002).”
Owen, A. M., Roberts, A. C., Polkey, C. E., Sahakian, B. J., & Robbins, T. W. (1991) · Neuropsychologia · doi:10.1016/0028-3932(91)90063-e · Cited by 657 · cited 2×
“During the extra-dimensional shift, a previously irrelevant attribute predicts reward requiring subjects to disengage attention from the previously relevant attribute and learn that a new attribute predicts reinforcement ( Owen et al. 1991, 1993; Dias et al. 1996a, b ;B irrell and Brown2000).”
Owen, A. M., Roberts, A. C., Hodges, J. R., & Robbins, T. W. (1993) · Brain · doi:10.1093/brain/116.5.1159 · Cited by 639 · cited 2×
“During the extra-dimensional shift, a previously irrelevant attribute predicts reward requiring subjects to disengage attention from the previously relevant attribute and learn that a new attribute predicts reinforcement ( Owen et al. 1991, 1993; Dias et al. 1996a, b ;B irrell and Brown2000).”
Locus coeruleus neurons in monkey are selectively activated by attended cues in a vigilance task
Aston-Jones, G., Rajkowski, J., Kubiak, P., & Alexinsky, T. (1994) · The Journal of Neuroscience · doi:10.1523/jneurosci.14-07-04467.1994 · Cited by 637 · cited 2×
“Norepinehrine has been shown to be critical to selective attention (Devauges and Sara 1990; Aston-Jones et al. 1994; Aston-Jones et al. 2000; Dalley et al. 2001; Dalley et al. 2004; Aston-Jones and Cohen 2005) and attentional set shifting (Lapiz and Morilak 2006; Lapiz et al.”
Orbital prefrontal cortex mediates reversal learning and not attentional set shifting in the rat
McAlonan, K., & Brown, V. J. (2003) · Behavioural Brain Research · doi:10.1016/j.bbr.2003.09.019 · Cited by 618 · cited 1×
“Reversal learning has consistently been shown to depend on the integrity of orbitofrontal, not medial, frontal cortex (Dias et al. 1996a, b; Schoenbaum 2000; McAlonan and Brown 2003).”
Berridge, C. W., Devilbiss, D. M., Andrzejewski, M. E., Arnsten, A. F. T., Kelley, A. E., Schmeichel, B., Hamilton, C., & Spencer, R. C. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.04.022 · Cited by 617 · cited 1×
“Recent data from Berridge and colleagues show that low doses of psychostimulants increase prefrontal catecholamine efflux but have less effect on catecholamine levels in the nucleus accumbens (Berridge et al. 2006).”
Catecholamine modulation of prefrontal cortical cognitive function
Arnsten, A. F. T. (1998) · Trends in Cognitive Sciences · doi:10.1016/s1364-6613(98)01240-6 · Cited by 604 · cited 14×
“Converging lines of data suggest that NE dysfunction underlies the symptoms of ADD (Friedman 1999; Viggiano et al. 2004a; Arnsten and Li 2005; Arnsten 2006; Faraone and Khan 2006), and our data support the hypothesis that atomoxetine can remediate cognitive deficits associated with noradrenergic dysfunction beyond imp…”
InfluentialBarkley, R. A. (1997) · Psychological Bulletin · doi:10.1037//0033-2909.121.1.65 · Cited by 580 · cited 2×
“…are hypothesized to underlie cognitive deficits in attention deficit disorder (ADD) while many studies support a role for dopaminergic dysfunction (Barkley 1997; Sagvolden and Sergeant 1998; Castellanos and Tannock 2002; Viggiano et al. 2004b), and recent data suggest that dysfunction in…”
Neurochemical Modulation of Response Inhibition and Probabilistic Learning in Humans
Chamberlain, S. R., Müller, U., Blackwell, A. D., Clark, L., Robbins, T. W., & Sahakian, B. J. (2006) · Science · doi:10.1126/science.1121218 · Cited by 573 · cited 3×
“The administration of atomoxetine to normal rats and humans has been shown to decrease impulsivity (Chamberlain et al. 2006; Blondeau and Dellu-Hagedorn 2007; Robinson et al. 2007) but less is known about the effects of this compound in attentional set shifting (Spencer et al. 1998; Chamberlain et…”
Granon, S., Passetti, F., Thomas, K. L., Dalley, J. W., Everitt, B. J., & Robbins, T. W. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-03-01208.2000 · Cited by 546 · cited 1×
“Higher baseline performance has been shown to be less responsive to facilitation by pharmacological manipulation (Turchi et al. 1995; Granon et al. 2000).”
Altered reinforcement mechanisms in attention-deficit/hyperactivity disorder.
Sagvolden, T., Aase, H., Zeiner, P., & Berger, D. (1998) · PubMed · Cited by 491
Catecholamine regulation of the prefrontal cortex
Arnsten, A. F. T. (1997) · Journal of Psychopharmacology · doi:10.1177/026988119701100208 · Cited by 488 · cited 2×
“2004b), and recent data suggest that dysfunction in norepinephrine (NE) may also contribute to cognitive impairments in ADD (Arnsten 1997; Arnsten 1998; Viggiano et al. 2004a; Arnsten 2006).”
Dias, R., Robbins, T. W., & Roberts, A. C. (1996) · Behavioral Neuroscience · doi:10.1037/0735-7044.110.5.872 · Cited by 476 · cited 2×
“During the extra-dimensional shift, a previously irrelevant attribute predicts reward requiring subjects to disengage attention from the previously relevant attribute and learn that a new attribute predicts reinforcement (Owen et al. 1991, 1993; Dias et al. 1996a, b; Birrell and Brown 2000).”
McGaughy, J., Kaiser, T., & Sarter, M. (1996) · Behavioral Neuroscience · doi:10.1037/0735-7044.110.2.247 · Cited by 435 · cited 2×
“Histological analyses DBH-positive fibers were quantified in cortical areas in a manner modified from that described by McGaughy et al. (1996).”
Self-citationSarter, M., & Bruno, J. P. (1999) · Neuroscience · doi:10.1016/s0306-4522(99)00487-x · Cited by 413 · cited 2×
“As acetylcholine has been consistently shown to be critical to certain types of attention (Chiba et al. 1995; Bucci et al. 1998; Sarter and Bruno 1998; Sarter and Bruno 1999; Robbins 2000; Sarter and Bruno 2000 ), it may be hypothesized that this increase in cortical acetylcholine is critical to the attentional improv…”
Stop-Signal Reaction-Time Task Performance: Role of Prefrontal Cortex and Subthalamic Nucleus
Eagle, D. M., Baunez, C., Hutcheson, D. M., Lehmann, O., Shah, A. P., & Robbins, T. W. (2008) · Cerebral Cortex · doi:10.1093/cercor/bhm044 · Cited by 404
Locus coeruleus and regulation of behavioral flexibility and attention
(2000) · Progress in Brain Research · doi:10.1016/s0079-6123(00)26013-5 · Cited by 400 · cited 2×
“Norepinehrine has been shown to be critical to selective attention (Devauges and Sara 1990; Aston-Jones et al. 1994; Aston-Jones et al. 2000; Dalley et al. 2001; Dalley et al. 2004; Aston-Jones and Cohen 2005) and attentional set shifting (Lapiz and Morilak 2006; Lapiz et al.”
Chemical neuromodulation of frontal-executive functions in humans and other animals
Robbins, T. W. (2000) · Experimental Brain Research · doi:10.1007/s002210000407 · Cited by 396 · cited 2×
“As acetylcholine has been consistently shown to be critical to certain types of attention (Chiba et al. 1995; Bucci et al. 1998; Sarter and Bruno 1998; Sarter and Bruno 1999; Robbins 2000; Sarter and Bruno 2000), it may be hypothesized that this increase in cortical acetylcholine is critical to the attentional improve…”
Fundamentals of Attention-Deficit/Hyperactivity Disorder: Circuits and Pathways
Arnsten, A. F. T. (2006) · The Primary Care Companion to The Journal of Clinical Psychiatry · Cited by 378
Robinson, E. S. J., Eagle, D. M., Mar, A. C., Bari, A., Banerjee, G., Jiang, X., Dalley, J. W., & Robbins, T. W. (2008) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301487 · Cited by 359
Altered reinforcement mechanisms in attention-deficit/hyperactivity disorder
Sagvolden, T., Aase, H., Zeiner, P., & Berger, D. (1998) · Behavioural Brain Research · doi:10.1016/s0166-4328(97)00170-8 · Cited by 345
Effectiveness and Tolerability of Tomoxetine in Adults With Attention Deficit Hyperactivity Disorder
Spencer, T., Biederman, J., Wilens, T., Prince, J., Hatch, M., Jones, J., Harding, M., Faraone, S. V., & Seidman, L. (1998) · American Journal of Psychiatry · doi:10.1176/ajp.155.5.693 · Cited by 335 · cited 3×
“…of atomoxetine to normal rats and humans has been shown to decrease impulsivity (Chamberlain et al. 2006; Blondeau and Dellu-Hagedorn 2007; Robinson et al. 2007) but less is known about the effects of this compound in attentional set shifting (Spencer et al. 1998; Chamberlain et al. 2007).”
Lapiz, M. D. S., & Morilak, D. A. (2006) · Neuroscience · doi:10.1016/j.neuroscience.2005.09.031 · Cited by 325 · cited 7×
“Noradrenergic deafferentation of prefrontal cortex selectively impairs performance on the extra-dimensional shift (McGaughy et al. 2008; Tait et al. 2007) in a manner similar to pharmacological manipulations that decrease cortical NE (Lapiz and Morilak 2006).”
InfluentialMcGaughy, J., Dalley, J. W., Morrison, C. H., Everitt, B. J., & Robbins, T. W. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-05-01905.2002 · Cited by 311 · cited 4×
“These data are similar to work on functional compensation in the cholinergic system showing that attentional tests tax the system beyond the capacity of compensatory increases found before testing begins ( McGaughy et al. 2002 ).”
InfluentialSelf-citationAtomoxetine improved response inhibition in adults with attention deficit/hyperactivity disorder
Chamberlain, S. R., del Campo, N., Dowson, J., Müller, U., Clark, L., Robbins, T. W., & Sahakian, B. J. (2007) · Biological Psychiatry · doi:10.1016/j.biopsych.2007.03.003 · Cited by 288 · cited 5×
“2007) but less is known about the effects of this compound in attentional set shifting (Spencer et al. 1998; Chamberlain et al. 2007).”
InfluentialDalley, J. W., McGaughy, J., O'Connell, M. T., Cardinal, R. N., Levita, L., & Robbins, T. W. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-13-04908.2001 · Cited by 277 · cited 1×
“Norepinehrine has been shown to be critical to selective attention (Devauges and Sara 1990; Aston-Jones et al. 1994; Aston-Jones et al. 2000; Dalley et al. 2001; Dalley et al. 2004; Aston-Jones and Cohen 2005) and attentional set shifting (Lapiz and Morilak 2006; Lapiz et al. 2007; Tait et al.…”
Self-citationMehta, M. A., Goodyer, I. M., & Sahakian, B. J. (2004) · Journal of Child Psychology and Psychiatry · doi:10.1111/j.1469-7610.2004.00221.x · Cited by 259 · cited 6×
“Performance in the ID/ED task is impaired in children with ADD and can be remediated by methylphenidate that increases both dopamine and NE levels ( Mehta et al. 2004 ).”
InfluentialChiba, A., Bucci, D., Holland, P., & Gallagher, M. (1995) · The Journal of Neuroscience · doi:10.1523/jneurosci.15-11-07315.1995 · Cited by 257 · cited 2×
“As acetylcholine has been consistently shown to be critical to certain types of attention (Chiba et al. 1995; Bucci et al. 1998; Sarter and Bruno 1998; Sarter and Bruno 1999; Robbins 2000; Sarter and Bruno 2000), it may be hypothesized that this increase in cortical acetylcholine is critical to the attentional improve…”
Eagle, D. M., & Robbins, T. W. (2003) · Behavioral Neuroscience · doi:10.1037/0735-7044.117.6.1302 · Cited by 252 · cited 2×
“Similar to reversal learning, response inhibition has been shown to be dependent on areas outside the medial prefrontal cortex (Eagle and Robbins 2003; Eagle et al. 2007).”
McGaughy, J., Ross, R. S., & Eichenbaum, H. (2008) · Neuroscience · doi:10.1016/j.neuroscience.2008.01.064 · Cited by 226 · cited 14×
“Noradrenergic deafferentation of prefrontal cortex selectively impairs performance on the extra-dimensional shift (McGaughy et al. 2008; Tait et al. 2007) in a manner similar to pharmacological manipulations that decrease cortical NE (Lapiz and Morilak 2006).”
InfluentialSelf-citationSchoenbaum, G., Chiba, A. A., & Gallagher, M. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-13-05179.2000 · Cited by 225
Mechanism of action of agents used in attention-deficit/hyperactivity disorder.
Wilens, T. E. (2006) · PubMed · Cited by 213
Fundamentals of attention-deficit/hyperactivity disorder: circuits and pathways.
Arnsten, A. F. T. (2006) · PubMed · Cited by 208
Bucci, D. J., Holland, P. C., & Gallagher, M. (1998) · The Journal of Neuroscience · doi:10.1523/jneurosci.18-19-08038.1998 · Cited by 205 · cited 2×
“As acetylcholine has been consistently shown to be critical to certain types of attention (Chiba et al. 1995; Bucci et al. 1998; Sarter and Bruno 1998; Sarter and Bruno 1999; Robbins 2000; Sarter and Bruno 2000), it may be hypothesized that this increase in cortical acetylcholine is critical to the attentional improve…”
Activation of the noradrenergic system facilitates an attentional shift in the rat
Devauges, V., & Sara, S. J. (1990) · Behavioural Brain Research · doi:10.1016/0166-4328(90)90118-x · Cited by 200 · cited 2×
“Norepinehrine has been shown to be critical to selective attention ( Devauges and Sara 1990; Aston-Jones et al. 1994; Aston-Jones et al. 2000; Dalley et al. 2001; Dalley et al. 2004; Aston-Jones and Cohen 2005) and attentional set shifting (Lapiz and Morilak 2006; Lapiz et al. 2007 ;T ait et al. 2007).”
A new inhibitor of norepinephrine uptake devoid of affinity for receptors in rat brain.
Wong, D. T., Threlkeld, P. G., Best, K. L., & Bymaster, F. P. (1982) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)33153-8 · Cited by 194 · cited 1×
“This profile is hypothesized to remediate cognitive impairments in patients with ADD and minimize addiction liability (Wong et al. 1982; Bymaster et al. 2002).”
On the narrow dip structure at 1.9 GeV/c2 in diffractive photoproduction
Frabetti, P. L., Cheung, H. W. K., Cumalat, J. P., Dallapiccola, C., Ginkel, J. F., Johns, W. E., Nehring, M. S., Vaandering, E. W., Butler, J. N., Cihangir, S., et al. (2004) · Physics Letters B · doi:10.1016/j.physletb.2003.10.071 · Cited by 187
Lesions of the dorsal noradrenergic bundle impair attentional set-shifting in the rat
Tait, D. S., Brown, V. J., Farovik, A., Theobald, D. E., Dalley, J. W., & Robbins, T. W. (2007) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2007.05612.x · Cited by 179 · cited 13×
“The rats in the present study were less impaired on the ED than subjects in Morilak’s or other studies (McGaughy et al. 2008; Lapiz and Morilak 2006; Tait et al. 2007).”
InfluentialCandidate gene studies of attention-deficit/hyperactivity disorder.
Faraone, S. V., & Khan, S. (2006) · PubMed · Cited by 166
Friedman, J. I., Adler, D. N., & Davis, K. L. (1999) · Biological Psychiatry · doi:10.1016/s0006-3223(99)00232-2 · Cited by 165
McGaughy, J., Everitt, B. J., Robbins, T. W., & Sarter, M. (2000) · Behavioural Brain Research · doi:10.1016/s0166-4328(00)00262-x · Cited by 159 · cited 2×
“…lesions (McGaughy et al. 2008; Tait et al. 2007) similar to findings with lesions of the cholinergic innervation to the cortex where sub-total depletions are sufficient to produce attentional impairments (McGaughy and Sarter 1998; McGaughy et al. 1999, 2000, 2002; Chudasama et al. 2004).”
Self-citationSarter, M., & Bruno, J. P. (1999) · Trends in Neurosciences · doi:10.1016/s0166-2236(98)01289-2 · Cited by 159 · cited 2×
“As acetylcholine has been consistently shown to be critical to certain types of attention (Chiba et al. 1995; Bucci et al. 1998; Sarter and Bruno 1998; Sarter and Bruno 1999; Robbins 2000; Sarter and Bruno 2000), it may be hypothesized that this increase in cortical acetylcholine is critical to the attentional improve…”
KRATOCHVIL, C. J., WILENS, T. E., GREENHILL, L. L., GAO, H., BAKER, K. D., FELDMAN, P. D., & GELOWITZ, D. L. (2006) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/01.chi.0000222788.34229.68 · Cited by 150 · cited 6×
“Atomoxetine (tomoxetine, LY 139603) is a newer generation, non-stimulant drug used to treat ADD (Caballero and Nahata 2003; Kratochvil et al. 2003; Christman et al. 2004; Kratochvil et al. 2006) with minimal addictive liability.”
InfluentialRoberts, A., Robbins, T. W., Everitt, B. J., & Muir, J. L. (1992) · Neuroscience · doi:10.1016/0306-4522(92)90241-s · Cited by 150 · cited 2×
“However, previous work from our lab and others have found that cholinergic lesions produce no effect on accuracy during the ED shift (Roberts et al. 1992; Tait et al. 2002; McGaughy et al. 2008).”
McGaughy, J., & Sarter, M. (1998) · Behavioral Neuroscience · doi:10.1037/0735-7044.112.6.1519 · Cited by 147 · cited 1×
“…lesions (McGaughy et al. 2008; Tait et al. 2007) similar to findings with lesions of the cholinergic innervation to the cortex where sub-total depletions are sufficient to produce attentional impairments (McGaughy and Sarter 1998; McGaughy et al. 1999, 2000, 2002; Chudasama et al. 2004).”
Self-citationDysfunctions in Dopamine Systems and ADHD: Evidence From Animals and Modeling
Viggiano, D., Vallone, D., & Sadile, A. (2004) · Neural Plasticity · doi:10.1155/np.2004.97 · Cited by 146 · cited 3×
“Converging lines of data suggest that NE dysfunction underlies the symptoms of ADD (Friedman 1999; Viggiano et al. 2004a; Arnsten and Li 2005; Arnsten 2006; Faraone and Khan 2006), and our data support the hypothesis that atomoxetine can remediate cognitive deficits associated with noradrenergic…”
Chudasama, Y., Dalley, J. W., Nathwani, F., Bouger, P., & Robbins, T. W. (2004) · Learning & Memory · doi:10.1101/lm.70904 · Cited by 144 · cited 1×
“…lesions (McGaughy et al. 2008; Tait et al. 2007) similar to findings with lesions of the cholinergic innervation to the cortex where sub-total depletions are sufficient to produce attentional impairments (McGaughy and Sarter 1998; McGaughy et al. 1999, 2000, 2002; Chudasama et al. 2004).”
Sun, Z., Ramsay, J. A., Guay, M., & Ramsay, B. (2006) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-006-0655-4 · Cited by 139
Dimensional Analysis of ADHD Subtypes in Rats
Blondeau, C., & Dellu-Hagedorn, F. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.06.030 · Cited by 133 · cited 3×
“The administration of atomoxetine to normal rats and humans has been shown to decrease impulsivity (Chamberlain et al. 2006; Blondeau and Dellu-Hagedorn 2007; Robinson et al. 2007) but less is known about the effects of this compound in attentional set shifting (Spencer et al. 1998; Chamberlain et…”
Holley, L. A., Turchi, J. N., Apple, C. A., & Sarter, M. F. (1995) · Psychopharmacology · doi:10.1007/bf02246150 · Cited by 131 · cited 1×
“A similar finding has been found in tests of sustained attention where increasing acetylcholine levels in intact animals impairs performance (Holley et al. 1995).”
McGaughy, J., Decker, M. W., & Sarter, M. (1999) · Psychopharmacology · doi:10.1007/s002130050991 · Cited by 128 · cited 1×
“…lesions (McGaughy et al. 2008; Tait et al. 2007) similar to findings with lesions of the cholinergic innervation to the cortex where sub-total depletions are sufficient to produce attentional impairments (McGaughy and Sarter 1998; McGaughy et al. 1999, 2000, 2002; Chudasama et al. 2004).”
Self-citationAbercrombie, E., & Zigmond, M. (1989) · The Journal of Neuroscience · doi:10.1523/jneurosci.09-11-04062.1989 · Cited by 125 · cited 1×
“Moreover, previous studies of noradrenergic depletions have found that lesions of 50% produce a system unable to maintain sufficient neurochemical compensation when challenged (Abercrombie and Zigmond 1989).”
Tzavara, E. T., Bymaster, F. P., Overshiner, C. D., Davis, R. J., Perry, K. W., Wolff, M. C., McKinzie, D. L., Witkin, J. M., & Nomikos, G. G. (2005) · Molecular Psychiatry · doi:10.1038/sj.mp.4001763 · Cited by 121 · cited 6×
“3 mg/kg and higher doses of atomoxetine increase prefrontal cholinergic efflux (Tzavara et al. 2007).”
InfluentialSolanto, M. V. (1984) · Psychological Bulletin · doi:10.1037/0033-2909.95.3.387 · Cited by 121 · cited 2×
“Psychostimulants used to alleviate these impairments increase both dopamine and NE levels ( Solanto 1984; Mehta et al. 2004; Wilens 2006).”
Atomoxetine, a Novel Treatment for Attention‐Deficit—Hyperactivity Disorder
Christman, A. K., Fermo, J. D., & Markowitz, J. S. (2004) · Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.24.11.1020.36146 · Cited by 97 · cited 6×
“Atomoxetine (tomoxetine, LY 139603) is a newer generation, non-stimulant drug used to treat ADD (Caballero and Nahata 2003; Kratochvil et al. 2003; Christman et al. 2004; Kratochvil et al. 2006) with minimal addictive liability.”
InfluentialLapiz, M. D. S., Bondi, C. O., & Morilak, D. A. (2007) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301235 · Cited by 95 · cited 4×
“2004; Aston-Jones and Cohen 2005) and attentional set shifting (Lapiz and Morilak 2006; Lapiz et al. 2007; Tait et al. 2007).”
InfluentialMilstein, J. A., Lehmann, O., Theobald, D. E. H., Dalley, J. W., & Robbins, T. W. (2007) · Psychopharmacology · doi:10.1007/s00213-006-0594-x · Cited by 94 · cited 1×
“Recent data support the most parsimonious explanation that attentional deficits after noradrenergic depletions are due to decreases in noradrenergic cortical release (Milstein et al. 2007; Tait et al. 2007).”
Kratochvil, C. J., Vaughan, B. S., Harrington, M. J., & Burke, W. J. (2003) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.4.7.1165 · Cited by 94 · cited 7×
“In addition to a low liability for abuse, it has fewer side effects relative to the psychostimulants also used to treat ADD (Caballero and Nahata 2003; Kratochvil et al. 2003; Christman et al. 2004; Kratochvil et al. 2006).”
InfluentialWee, S., & Woolverton, W. L. (2004) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2004.03.010 · Cited by 90 · cited 2×
“1994; McGaughy and Sarter 1995) and is equal to doses used in other animal studies (Wee and Woolverton 2004) The current data suggest it may be as effective as higher doses at increasing cortical NE levels but concurrent microdialysis is required to elucidate the neurochemical effects of this dose.”
Effects of nicotinic acetylcholine receptor ligands on behavioral vigilance in rats
Turchi, J. N., Holley, L. A., & Sarter, M. F. (1995) · Psychopharmacology · doi:10.1007/bf02245840 · Cited by 84 · cited 1×
“Higher baseline performance has been shown to be less responsive to facilitation by pharmacological manipulation (Turchi et al. 1995; Granon et al. 2000).”
Atomoxetine hydrochloride for the treatment of attention-deficit/hyperactivity disorder
Caballero, J., & Nahata, M. C. (2003) · Clinical Therapeutics · doi:10.1016/s0149-2918(03)90092-0 · Cited by 75 · cited 6×
“Atomoxetine (tomoxetine, LY 139603) is a newer generation, non-stimulant drug used to treat ADD (Caballero and Nahata 2003; Kratochvil et al. 2003; Christman et al. 2004; Kratochvil et al. 2006) with minimal addictive liability.”
InfluentialCrossmodal divided attention in rats: effects of chlordiazepoxide and scopolamine
McGaughy, J. A., Turchi, J. N., & Sarter, M. F. (1994) · Psychopharmacology · doi:10.1007/bf02244774 · Cited by 74 · cited 2×
“…of this dose was based on previous work showing that attentional testing is more sensitive than other behavioral tests to the effects of drugs (McGaughy et al. 1994; McGaughy and Sarter 1995) and is equal to doses used in other animal studies (Wee and Woolverton 2004) The current data suggest…”
Self-citationViggiano, D., Ruocco, L. A., Arcieri, S., & Sadile, A. G. (2004) · Neural Plasticity · doi:10.1155/np.2004.133 · Cited by 71 · cited 5×
“Imbalances in catecholamine systems are hypothesized to underlie cognitive deficits in attention deficit disorder (ADD) while many studies support a role for dopaminergic dysfunction (Barkley 1997; Sagvolden and Sergeant 1998; Castellanos and Tannock 2002; Viggiano et al. 2004b), and recent data suggest that dysfuncti…”
InfluentialSarter, M. F., & Bruno, J. P. (1998) · Brain and Cognition · doi:10.1006/brcg.1998.1035 · Cited by 70 · cited 2×
“As acetylcholine has been consistently shown to be critical to certain types of attention (Chiba et al. 1995; Bucci et al. 1998; Sarter and Bruno 1998; Sarter and Bruno 1999; Robbins 2000; Sarter and Bruno 2000), it may be hypothesized that this increase in cortical acetylcholine is critical to the attentional improve…”
Update on Bipolar Disorder and Substance Abuse: Recent Findings and Treatment Strategies
Ostacher, M. J., & Sachs, G. S. (2006) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.0906e10 · Cited by 56
Wilens, T. E., Zusman, R. M., Hammerness, P. G., Podolski, A., Whitley, J., Spencer, T. J., Gignac, M., & Biederman, J. (2006) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v67n0502 · Cited by 54
Psychosocial Strategies to Improve Concordance and Adherence in Bipolar Disorder
Reilly-Harrington, N., & Sachs, G. S. (2006) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.0706e04 · Cited by 33
McGaughy, J. A., & Sarter, M. F. (1995) · The Journals of Gerontology Series A · doi:10.1093/gerona/50a.2.b90 · Cited by 20 · cited 2×
“The inclusion of this dose was based on previous work showing that attentional testing is more sensitive than other behavioral tests to the effects of drugs (McGaughy et al. 1994; McGaughy and Sarter 1995) and is equal to doses used in other animal studies (Wee and Woolverton 2004) The current data suggest it may be a…”
Self-citation
Research works printed but not linked: 1
- Tait D, McGaughy J, Latimer MP, Brown V (2002) 192 IgG-saporin lesions of the cholinergic basal forebrain do not impair attentional set-shifting, but do increase latency to dig. Proceedings of the Society for Neuroscience, New Orleans, LA
Cited by
Inhibition and impulsivity: behavioral and neural basis of response control
Bari, A., & Robbins, T. W. (2013) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2013.06.005 · Cited by 1,921
The Neuropsychopharmacology of Fronto-Executive Function: Monoaminergic Modulation
Robbins, T. W., & Arnsten, A. F. T. (2009) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.051508.135535 · Cited by 957
“Thus, doses of atomoxetine that impair attentional set shifting in normal rats appear to improve stop-signal performance (Newman et al. 2008).”
BackgroundLogue, S. F., & Gould, T. J. (2014) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2013.08.007 · Cited by 477
“In rats, lesions producing substantial decreases in mPFC NE impaired attention (Milstein et al. 2007) and set-shifting (McGaughy et al. 2008; Tait et al. 2007) and this deficit was reversed by the selective NE reuptake inhibitor, atomoxetine (Newman et al. 2008).”
BackgroundLearning and cognitive flexibility: frontostriatal function and monoaminergic modulation
Kehagia, A. A., Murray, G. K., & Robbins, T. W. (2010) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2010.01.007 · Cited by 398
“Results from the same laboratory extended these findings to the beneficial effects of atomoxetine, a NA reuptake inhibitor used for the treatment of attention deficit/hyperactivity disorder (ADHD), which at the low doses employed in that study only augments cortical NA [44 ].”
ResultArnsten, A. F. T., & Pliszka, S. R. (2011) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2011.01.020 · Cited by 383
“Atomoxetine improves measures of PFC cognitive function in rats (Newman et al., 2008; Robinson et al., 2008; Seu et al., 2009), monkeys (Gamo et al., 2010; Seu et al., 2009), and humans (Chamberlain et al., 2007; Chamberlain et al., 2006).”
Background
Metadata
- Authors
- Newman, L. A., Darling, J., & McGaughy, J.
- Affiliations
- University of New Hampshire (US)
- Corresponding author
- McGaughy, Jill
- Venue
- Psychopharmacology
- Published
- 2008-06-22
- Volume
- 200
- Issue
- 1
- Pages
- 39-50
- ISSN
- 0033-3158 (ISSN-L)
- 1432-2072
- PMC
- PMC10719959
- OpenAlex
- W2034057430
- Cited by
- 137
- References
- 77
- Citations by year
- 2026: 5 · 2025: 6 · 2024: 4 · 2023: 11 · 2022: 4 · 2021: 4 · 2020: 3 · 2019: 9 · 2018: 6 · 2017: 5 · 2016: 9 · 2015: 9 · 2014: 11 · 2013: 10 · 2012: 8
- FWCI
- 7.73
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Psychopharmacology (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institute of Mental Health (R21MH087921)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Attention Deficit Hyperactivity Disorder
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Life Sciences › Neuroscience › Cognitive Neuroscience › Neural and Behavioral Psychology Studies
- Keywords
- atomoxetine, medial prefrontal cortex, set-shifting, norepinephrine reuptake inhibition, attention deficit disorder, executive function, dose-dependent effects
- MeSH terms
- Atomoxetine Hydrochloride, Animals, Attention, Attention Deficit Disorder with Hyperactivity, Behavior, Animal, Discrimination Learning, Disease Models, Animal, Dose-Response Relationship, Drug, Norepinephrine, Propylamines, Psychomotor Performance, Prefrontal Cortex, Adrenergic Uptake Inhibitors, Rats, Long-Evans, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.